InMed Pharmaceuticals Inc (NASDAQ:INM) has a beta value of 0.49 and has seen 1.23 million shares traded in the last trading session. The company, currently valued at $6.35M, closed the last trade at $3.17 per share which meant it gained $0.42 on the day or 15.27% during that session. The INM stock price is -395.27% off its 52-week high price of $15.70 and 45.74% above the 52-week low of $1.72. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.23 million shares traded. The 3-month trading volume is 3.22 million shares.
The consensus among analysts is that InMed Pharmaceuticals Inc (INM) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
InMed Pharmaceuticals Inc (NASDAQ:INM) trade information
Sporting 15.27% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the INM stock price touched $3.17 or saw a rise of 3.35%. Year-to-date, InMed Pharmaceuticals Inc shares have moved -39.73%, while the 5-day performance has seen it change 16.12%. Over the past 30 days, the shares of InMed Pharmaceuticals Inc (NASDAQ:INM) have changed 24.31%. Short interest in the company has seen 32852.0 shares shorted with days to cover at 0.01.
InMed Pharmaceuticals Inc (INM) estimates and forecasts
The company’s shares have lost -29.71% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 53.87% over the past 5 years.
INM Dividends
InMed Pharmaceuticals Inc is expected to release its next earnings report on 2022-Sep-23 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
InMed Pharmaceuticals Inc (NASDAQ:INM)’s Major holders
Insiders own 1.45% of the company shares, while shares held by institutions stand at 10.18% with a share float percentage of 10.33%. Investors are also buoyed by the number of investors in a company, with InMed Pharmaceuticals Inc having a total of 7.0 institutions that hold shares in the company. The top two institutional holders are SABBY MANAGEMENT, LLC with over 0.31 million shares worth more than $81571.0. As of 2024-06-30, SABBY MANAGEMENT, LLC held 3.1961% of shares outstanding.
The other major institutional holder is VIRTU FINANCIAL LLC, with the holding of over 86684.0 shares as of 2024-06-30. The firm’s total holdings are worth over $23000.0 and represent 0.9017% of shares outstanding.
